Stockreport

Avadel Pharmaceuticals Announces Restructuring to Focus on FT218 Clinical Development Program

Avadel Pharmaceuticals plc - Ordinary Share  (AVDL) 
Last avadel pharmaceuticals plc - ordinary share earnings: 3/12 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: avadel.com
PDF - Company cost structure expected to be reduced by $70 to $75 million in 2019 – - Approximately $100 million in cash and marketable securities at December 31, 2018 – D [Read more]